Contrasting Astrana Health (NASDAQ:ASTH) and 6D Global Technologies (OTCMKTS:SIXD)

Astrana Health (NASDAQ:ASTH) and 6D Global Technologies (OTCMKTS:SIXD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, institutional ownership, risk and analyst recommendations.

Risk & Volatility

Astrana Health has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, 6D Global Technologies has a beta of 15, indicating that its stock price is 1,400% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Astrana Health and 6D Global Technologies, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0	2	5	1	2.88
6D Global Technologies	0	0	0	0	0.00

Astrana Health presently has a consensus price target of $65.60, indicating a potential upside of 86.89%. Given Astrana Health’s stronger consensus rating and higher probable upside, research analysts plainly believe Astrana Health is more favorable than 6D Global Technologies.

Earnings and Valuation

This table compares Astrana Health and 6D Global Technologies”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$1.39 billion	1.42	$60.72 million	$1.30	27.00
6D Global Technologies	N/A	N/A	N/A	N/A	N/A

Astrana Health has higher revenue and earnings than 6D Global Technologies.

Institutional & Insider Ownership

52.8% of Astrana Health shares are owned by institutional investors. 8.5% of Astrana Health shares are owned by insiders. Comparatively, 30.2% of 6D Global Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Astrana Health and 6D Global Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Astrana Health	3.63%	9.37%	5.32%
6D Global Technologies	N/A	N/A	N/A

Summary

Astrana Health beats 6D Global Technologies on 9 of the 11 factors compared between the two stocks.

About Astrana Health

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

About 6D Global Technologies

6D Global Technologies, Inc. is a holding company which engages in the digital business solutions. It operates through the Content Management Systems and Information Technology (IT) Staffing segments. The Content Management Systems segment offers web content management solutions, marketing cloud solutions, mobile applications, analytics, front-end user experience and design and marketing automation. The IT staffing segment provides contract and contract-to-hire IT professional staffing services. The company was founded by Tejune Kang on February 9, 2014 and is headquartered in New York, NY.